|
Acton Says FDA Oks SNDA For AEROSPAN Inhalation Aerosol For Asthma
RTT News … has approved the sNDA (Supplemental New Drug Application) for AEROSPAN Inhalation Aerosol, a hydrofluoroalkane orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients … |
View full post on asthma – Google News